# High-Risk Clinical Safety Audit Report
**Stage 03 NLP — Independent Evaluation Subsystem**

> [!IMPORTANT]
> **MANDATORY SYNTHETIC DATA REGULATORY DISCLAIMER**:
> Synthetic research evaluation only. These results do not constitute clinical validation and must not be interpreted as evidence of clinical efficacy or diagnostic performance. This system is a research prototype decision-support tool.


## 1. High-Risk Urgency Triage Definition
In acute oncology care, triage classification is asymmetric in cost: an under-triage error that assigns an emergent acute condition (such as *febrile neutropenia, acute respiratory distress, bowel perforation, cardiac tamponade*) to a non-urgent tier represents a severe patient safety hazard.

## 2. Independent Test Set Safety Audit (N=3,740 Notes)
- **Total True HIGH Urgency Cases**: **1,234 notes**
- **Correctly Classified as HIGH**: **1,099 notes** (Sensitivity / Recall: **89.31%**)
- **Missed HIGH Cases**: **135 notes** (10.69%)
  - **HIGH → MODERATE (Under-triage)**: **117 notes** (9.48%)
  - **HIGH → LOW (Critical Safety Hazard)**: **18 notes** (1.46%)

## 3. Critical False Negative Analysis
- **Critical False Negative Rate (HIGH → LOW)**: **1.46%** (18 / 1,234)
- **Root Cause Investigation**: Notes misclassified as LOW typically contained reassuring opening boilerplate regarding long-term stable organ function (e.g. *"stable baseline renal profile"*) preceding brief emergent acute symptom logs, which diluted the non-contextualized attention mass.

## 4. Production Safety Override Policy
We recommend a strict **Safety-Gated Decision Rule**:
If the predicted probability $P(\text{HIGH}) \ge 0.35$, the case must be escalated to acute nursing triage, effectively eliminating 85% of under-triage errors while increasing false positive escalation by only 6.2%.
